“Prime Target for Repeal: Obamacare’s Medical Device Excise Tax”
American Bar Association Health eSource, Volume 12, Issue 2 (October 2015) 11/03/15 By Jennifer J. Hennessy
Below is an excerpt:
One of the prime targets for legislative repeal this fiscal year appears to be the medical device excise tax implemented under the Patient Protection and Affordable Care Act1 (PPACA) as amended by the Health Education Reconciliation Act2 passed in 2010. Whether the 2.3 percent tax on medical device sales imposed upon the medical device manufacturing industry is justified by PPACA's increased volume of insured patients and prospective device sales is a highly contested matter. According to the Congressional Budget Office, this tax was estimated to generate $29 billion in revenue over the course of a decade.3 Nonetheless, since its passage, numerous proposals have been made to repeal the tax. Now in 2015, such efforts have significant momentum as legislators of both parties are rapidly joining ranks to provide support to the most recent effort for repeal.